January 12, 2011 Patient Self-report for Evaluating Mild Cognitive Impairment and Prodromal Alzheimer’s Disease
October 5, 2010 Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury
October 5, 2010 Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium
January 9, 2010 Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success
May 20, 2024 Practical considerations for the use of clinical outcome assessments (COAs) in pediatric clinical research with examples from pediatric gastroenterology
May 20, 2024 Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study Bodart, S B B, Crescioni, M E S,, Flood, E and on behalf of the ePRO C. Perceived Burden of Completion of Patient-Reported Outcome
May 20, 2024 Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
May 20, 2024 Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure